ghk-cu clinical trial dosage Peptide GHK-Cu / KPV · Disguised
Description
Levels should be in the normal or high-normal range if supplementation is adequate
This allows her to reassess, and make adjustments or additions if theyre needed (or desired)
Today 51 , 393401 (2021)
Foot Ankle Clin 12:553567 Hsieh MJ, Liu HT, Wang CN, Huang HY, Lin Y, Ko YS, Wang JS, Chang VH, Pang JH (2017) Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation
BPC-157 increases angiogenesis and growth hormone receptors
Having both formulas means you can match intensity to need (simple care most days, active treatment when required)
